Amarin management update

Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Business: Metabolic, Cardiovascular, Neurology Departing: Thomas Lynch as CEO while remaining chairman; Head of R&D Declan Doogan becomes interim CEO ...